Kat6a Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of KAT6A mRNA CTD PMID:20068009|PMID:32145629 Kat6a Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of KAT6A mRNA CTD PMID:27291303 Kat6a Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of KAT6A mRNA CTD PMID:23829299 Kat6a Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1312591 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of KAT6A mRNA CTD PMID:31388691 Kat6a Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KAT6A mRNA CTD PMID:32109520|PMID:34747641 Kat6a Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KAT6A mRNA CTD PMID:33387578 Kat6a Rat 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of KAT6A mRNA CTD PMID:21346803 Kat6a Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1312591 6480464 bisphenol S results in decreased expression of KAT6A mRNA CTD PMID:39298647 Kat6a Rat acrolein multiple interactions ISO RGD:1312590 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Kat6a Rat aflatoxin B1 increases methylation ISO RGD:1312590 6480464 Aflatoxin B1 results in increased methylation of KAT6A gene CTD PMID:27153756 Kat6a Rat alpha-pinene multiple interactions ISO RGD:1312590 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Kat6a Rat arsenite(3-) multiple interactions ISO RGD:1312590 6480464 arsenite inhibits the reaction [G3BP1 protein binds to KAT6A mRNA] CTD PMID:32406909 Kat6a Rat benzene increases expression ISO RGD:1312590 6480464 Benzene results in increased expression of KAT6A mRNA CTD PMID:19162166 Kat6a Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312590 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KAT6A mRNA CTD PMID:19150397 Kat6a Rat benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312590 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KAT6A mRNA CTD PMID:26238291 Kat6a Rat bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1312591 6480464 Diethylhexyl Phthalate results in decreased expression of KAT6A mRNA CTD PMID:33754040 Kat6a Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KAT6A mRNA CTD PMID:25181051 Kat6a Rat bisphenol A increases expression ISO RGD:1312590 6480464 bisphenol A results in increased expression of KAT6A mRNA CTD PMID:36232920 Kat6a Rat bisphenol A decreases methylation ISO RGD:1312590 6480464 bisphenol A results in decreased methylation of KAT6A gene CTD PMID:31601247 Kat6a Rat bisphenol A multiple interactions ISO RGD:1312590 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene CTD PMID:31601247 Kat6a Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of KAT6A mRNA CTD PMID:32145629 Kat6a Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KAT6A mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998|PMID:36803626 Kat6a Rat bisphenol F increases expression ISO RGD:1312591 6480464 bisphenol F results in increased expression of KAT6A mRNA CTD PMID:38685157 Kat6a Rat caffeine increases phosphorylation ISO RGD:1312590 6480464 Caffeine results in increased phosphorylation of KAT6A protein CTD PMID:35688186 Kat6a Rat carbon nanotube decreases expression ISO RGD:1312591 6480464 Nanotubes, Carbon results in decreased expression of KAT6A mRNA CTD PMID:25554681 Kat6a Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of KAT6A mRNA CTD PMID:23125180 Kat6a Rat chlorpyrifos decreases expression ISO RGD:1312591 6480464 Chlorpyrifos results in decreased expression of KAT6A mRNA CTD PMID:37019170 Kat6a Rat cisplatin increases phosphorylation ISO RGD:1312591 6480464 Cisplatin results in increased phosphorylation of KAT6A protein CTD PMID:22006019 Kat6a Rat cisplatin decreases expression ISO RGD:1312590 6480464 Cisplatin results in decreased expression of KAT6A mRNA CTD PMID:27594783 Kat6a Rat copper(II) sulfate increases expression ISO RGD:1312590 6480464 Copper Sulfate results in increased expression of KAT6A mRNA CTD PMID:19549813 Kat6a Rat coumarin increases phosphorylation ISO RGD:1312590 6480464 coumarin results in increased phosphorylation of KAT6A protein CTD PMID:35688186 Kat6a Rat coumestrol decreases expression ISO RGD:1312590 6480464 Coumestrol results in decreased expression of KAT6A mRNA CTD PMID:19167446 Kat6a Rat crocidolite asbestos decreases expression ISO RGD:1312590 6480464 Asbestos, Crocidolite results in decreased expression of KAT6A mRNA CTD PMID:29523930 Kat6a Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of KAT6A mRNA CTD PMID:23640034 Kat6a Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of KAT6A mRNA CTD PMID:23640034 Kat6a Rat deguelin increases expression ISO RGD:1312590 6480464 deguelin results in increased expression of KAT6A mRNA CTD PMID:33512557 Kat6a Rat Dibutyl phosphate affects expression ISO RGD:1312590 6480464 di-n-butylphosphoric acid affects the expression of KAT6A mRNA CTD PMID:37042841 Kat6a Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of KAT6A mRNA CTD PMID:21266533 Kat6a Rat dicrotophos increases expression ISO RGD:1312590 6480464 dicrotophos results in increased expression of KAT6A mRNA CTD PMID:28302478 Kat6a Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of KAT6A mRNA CTD PMID:25152437 Kat6a Rat dorsomorphin multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6a Rat enzyme inhibitor multiple interactions ISO RGD:1312590 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... CTD PMID:23301498 Kat6a Rat ethanol increases expression ISO RGD:1312591 6480464 Ethanol results in increased expression of KAT6A mRNA CTD PMID:30319688 Kat6a Rat folpet increases expression ISO RGD:1312591 6480464 folpet results in increased expression of KAT6A mRNA CTD PMID:31558096 Kat6a Rat formaldehyde decreases expression ISO RGD:1312590 6480464 Formaldehyde results in decreased expression of KAT6A mRNA CTD PMID:20655997 Kat6a Rat FR900359 affects phosphorylation ISO RGD:1312590 6480464 FR900359 affects the phosphorylation of KAT6A protein CTD PMID:37730182 Kat6a Rat fulvestrant multiple interactions ISO RGD:1312590 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene CTD PMID:31601247 Kat6a Rat fulvestrant decreases methylation ISO RGD:1312590 6480464 Fulvestrant results in decreased methylation of KAT6A gene CTD PMID:31601247 Kat6a Rat gallic acid decreases expression ISO RGD:1312590 6480464 Gallic Acid results in decreased expression of KAT6A mRNA CTD PMID:34408198 Kat6a Rat geldanamycin increases expression ISO RGD:1312590 6480464 geldanamycin results in increased expression of KAT6A mRNA CTD PMID:26705709 Kat6a Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KAT6A mRNA CTD PMID:22061828 Kat6a Rat lead diacetate increases expression ISO RGD:1312591 6480464 lead acetate results in increased expression of KAT6A mRNA CTD PMID:20542052 Kat6a Rat linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of KAT6A protein CTD PMID:28086193 Kat6a Rat mercury dibromide decreases expression ISO RGD:1312590 6480464 mercuric bromide results in decreased expression of KAT6A mRNA CTD PMID:26272509 Kat6a Rat mercury dibromide multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6a Rat mercury dichloride decreases expression ISO RGD:1312590 6480464 Mercuric Chloride results in decreased expression of KAT6A mRNA CTD PMID:27188386 Kat6a Rat methamphetamine increases expression ISO RGD:1312591 6480464 Methamphetamine results in increased expression of KAT6A mRNA CTD PMID:26307267 Kat6a Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of KAT6A mRNA CTD PMID:30467583 Kat6a Rat methidathion decreases expression ISO RGD:1312591 6480464 methidathion results in decreased expression of KAT6A mRNA CTD PMID:34813904 Kat6a Rat N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:1312590 6480464 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of KAT6A mRNA CTD PMID:12756304 Kat6a Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA CTD PMID:25729387 Kat6a Rat ozone multiple interactions ISO RGD:1312590 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Kat6a Rat p-chloromercuribenzoic acid decreases expression ISO RGD:1312590 6480464 p-Chloromercuribenzoic Acid results in decreased expression of KAT6A mRNA CTD PMID:26272509 Kat6a Rat p-chloromercuribenzoic acid multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6a Rat panobinostat multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Kat6a Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1312591 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KAT6A mRNA CTD PMID:36331819 Kat6a Rat phenylmercury acetate decreases expression ISO RGD:1312590 6480464 Phenylmercuric Acetate results in decreased expression of KAT6A mRNA CTD PMID:26272509 Kat6a Rat phenylmercury acetate multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6a Rat SB 431542 multiple interactions ISO RGD:1312590 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Kat6a Rat sodium arsenite increases expression ISO RGD:1312591 6480464 sodium arsenite results in increased expression of KAT6A mRNA CTD PMID:36209798 Kat6a Rat Soman increases expression EXP 6480464 Soman results in increased expression of KAT6A mRNA CTD PMID:19281266 Kat6a Rat thimerosal decreases expression ISO RGD:1312590 6480464 Thimerosal results in decreased expression of KAT6A mRNA CTD PMID:27188386 Kat6a Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KAT6A mRNA CTD PMID:34492290 Kat6a Rat titanium dioxide increases methylation ISO RGD:1312591 6480464 titanium dioxide results in increased methylation of KAT6A promoter CTD PMID:35295148 Kat6a Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KAT6A mRNA CTD PMID:25729387 Kat6a Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA CTD PMID:25729387 Kat6a Rat trichostatin A decreases expression ISO RGD:1312590 6480464 trichostatin A results in decreased expression of KAT6A mRNA CTD PMID:24935251 Kat6a Rat troglitazone decreases expression ISO RGD:1312591 6480464 troglitazone results in decreased expression of KAT6A mRNA CTD PMID:28973697 Kat6a Rat tungsten decreases expression ISO RGD:1312591 6480464 Tungsten results in decreased expression of KAT6A mRNA CTD PMID:30912803 Kat6a Rat valproic acid decreases methylation ISO RGD:1312590 6480464 Valproic Acid results in decreased methylation of KAT6A gene CTD PMID:29154799 Kat6a Rat valproic acid decreases expression ISO RGD:1312590 6480464 Valproic Acid results in decreased expression of KAT6A mRNA CTD PMID:23179753|PMID:24935251|PMID:28001369 Kat6a Rat valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of KAT6A mRNA CTD PMID:29427782